ABCG2 and acute myeloid leukemia: Although cyclosporin A has a high affinity for binding to ABC transporters, its addition to the combination of mitoxantrone and etoposide did not improve treatment outcomes for patients with refractory or relapsing acute myeloid leukemia (AML) who had developed resistance to these chemotherapies [77].